Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results

Chest

Volumn 118, Issue 6, 2000, Pages 1591-1597

  Desmarquest, Pascale ^a   Feldmann, Delphine ^b   Tamalat, Aline ^a   Boule, Michele ^a   Fauroux, Brigitte ^a   Tournier, Guy ^a   Clement, Annick ^a  

^a INSERM   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Children; Cystic fibrosis; Genotype; Sweat chloride tests

Indexed keywords

CHLORIDE; DNA; THYMIDINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ARTICLE; BLOOD GAS ANALYSIS; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENOTYPE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; SPUTUM CULTURE; SWEAT TEST;

EID: 0034545223     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.6.1591     Document Type: Article

References (44)

1. Cystic fibrosis
2. Physiological basis of cystic fibrosis: A historical perspective
3. The genetics of cystic fibrosis lung disease
4. Structure and function of the CFTR chloride channel
5. CFTR is a conductance regulator as well as chloride channel
6. Role of CFTR in airway disease
7. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
8. Cystic fibrosis
9. The innate immune system in cystic fibrosis lung disease
10. The genesis of cystic fibrosis lung disease
11. The relation between genotype and phenotype in cystic fibrosis: Analysis of the most common mutation (ΔF508)
12. Genotype-phenotype correlations in cystic fibrosis
13. Correlation between genotype and phenotype in patients with cystic fibrosis
14. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis
15. Sweat testing for the diagnosis of cystic fibrosis: Practical considerations
16. Intermediate-range sweat chloride concentration and Pseudomonas bronchitis: A cystic fibrosis variant with preservation of exocrine pancreatic function
17. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis
18. A novel mutation in cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
19. Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels
20. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis
21. The diagnosis of cystic fibrosis: A consensus statement
22. Flow-volume curve in children in health and disease
23. Lung function in children with recurrent bronchitis
24. Distinct cytokine profiles in sputum from children with cystic fibrosis (CF) and from non CF children with chronic inflammatory airway disease
25. CFTR gene analysis in cystic fibrosis patients: Detection of 91% of molecular defects and identification of the novel mutation D979V
26. Clinical presentation of patients carrying the 5T thymidine tract in intron 8-from healthy individuals to typical CF
27. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations
28. Intracellular CFTR: Localization and function
29. 3849+10kb C T mutation and disease severity in cystic fibrosis
30. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+10 kb C T mutation
31. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test
32. Variable levels of aberrantly spliced CFTR mRNA transcribed from the 5T allele: The cause for variable disease severity among individuals and between organs of the same individual [letter]
33. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentation
34. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
35. Cystic fibrosis genotype-phenotype consortium: Correlation between genotype and phenotype in the patients with cystic fibrosis
36. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis
37. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis
38. Biosynthesis and degradation of CFTR
39. Disseminated bronchiectasis and cystic fibrosis gene mutations
40. State of the art: Cystic fibrosis
41. Treatment of airway inflammation in cystic fibrosis
42. Recent advances in the understanding and treatment of cystic fibrosis
43. Implications of early inflammation and infection in cystic fibrosis: A review of new and potential interventions
44. Novel pharmacological therapies for cystic fibrosis